Affimed Presents Data at ASH 2018 Substantiating Opportunity for AFM13 as Mono- and Combination Therapy in CD30-Positive Tumors
December 3, 2018
December 3, 2018
November 28, 2018
November 8, 2018
November 7, 2018
November 1, 2018
October 31, 2018
October 8, 2018
August 30, 2018
August 27, 2018
August 8, 2018